BioSpace News Archive

Breg, Inc., an orthopedic bracing provider with market-leading consulting and technology programs, has launched the next generation of its paperless workflow management system for orthopedic providers, Breg Vision® 7.0, in Apple’s app store.

Ridgeback Biotherapeutics LP, a closely held biotechnology company, today announced that the Food and Drug Administration has recently granted mAb114, an experimental treatment for Ebola, Orphan Drug Designation.

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced the completion of its review of strategic alternatives, following which the Company’s Board of Directors is implementing a series of measures designed to extend Merrimack’s cash runway into 2027 and preserve its ability to capture the potential remaining ONIVYDE-related milestones resulting from its 2017 asset sale to Ipsen S.A

Innovent Biologics, Inc. announced that the preliminary results of sintilimab, the anti-PD-1 antibody that co-developed with Eli Lilly and Company, in combination with chemotherapy for 1L advanced or metastatic non-small cell lung cancer were presented at the 55th Annual Meeting of the American Society of Clinical Oncology

MedX Health Corp. announced its results for the three-months ended March 31, 2019, which are also available on SEDAR.

Whole Biome, an evidence-based microbiome company, has announced that it has secured $35 million in Series B financing.

All aspects of human health, from gene regulation in cells to the efficacy of drugs are governed by the interactions of individual molecules. Advancing human health thus depends critically on our ability to observe and interpret the finest details of these interactions

MilliporeSigma, a leading science and technology company, today announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center.

Passage Bio, a genetic medicines company developing AAV-delivered gene therapies for the treatment of rare monogenic central nervous system diseases, today announced that its third clinical trial program will be for infantile Krabbe disease, an inherited disease that causes progressive damage to the nervous system.

If your seasonal allergy symptoms are ruining your day, consider looking into the relationship between your gut health and allergic reactions to your environment.